Navigation Links
Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles
Date:9/15/2009

BURBANK, Calif., Sept. 15 /PRNewswire-USNewswire/ -- A new partnership of Providence Health & Services, Childrens Hospital Los Angeles and the Childrens Hospital Los Angeles Medical Group has been developed to treat young adults with cancer, providing diagnostics and treatment for a group that nationwide falls in a gap between adult and pediatric health care.

The Adolescent & Young Adult Cancer Program is believed to be the first such endeavor in the United States developed as a partnership between a pediatric academic medical center and a community-based cancer program.

The AYA Program will serve patients, 18 to 39, and will be housed at Providence Saint Joseph Medical Center's new Roy and Patricia Disney Family Cancer Center, scheduled to open early next year on the Burbank campus.

It will be jointly directed by Raul Mena, M.D., medical director of the Disney Cancer Center, and Stuart E. Siegel, M.D., head of the Division of Hematology/Oncology and director of the Childrens Center for Cancer and Blood Disease at Childrens Hospital, and professor and vice chairman of pediatrics at the Keck School of Medicine of the University of Southern California.

"These young cancer patients historically have fallen between the cracks," Dr. Mena said. "A 20-year-old who has been treated for cancer as a teenager is no longer a pediatric case, but his treatment is not the same as for a 55-year-old patient. They have very special needs. This may include not only treatments and research studies that are specific for this group of patients but also programs that deal with the long term side effects of therapy."

Dr. Siegel, a nationally recognized expert on AYA cancers and current co-chairman of the Standards Task Force for the Lance Armstrong Foundation/Young Adult Alliance, said that the new joint program will be desig
'/>"/>

SOURCE Providence Saint Joseph Medical Center
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Unique Webisode Series, The O Mission, Helps Normalize Sexual Health Conversations for Young Adults as Social Networking Changes the Dating Scene
2. Young Survivor and Advocate, Amanda Nixon, Named 2009 Honorary Breast Cancer Survivor by Susan G. Komen for the Cure, San Diego
3. APDA/NPF Young Onset Parkinsons Conference Series Kick-Off in Dallas, October 23-24
4. Alzheimers Gene Affects Brains of Young Adults
5. Young People at High Risk of Death Worldwide
6. FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males
7. Testing Young Athletes for Heart Defects May Save Lives
8. Young Animals May Be Able to Erase Bad Memories
9. Anthem Life & Disability Insurance Company Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope With Losing a Loved One
10. Blue Cross Blue Shield of Georgia Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with Losing a Loved One
11. Anthem Life Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with Losing a Loved One
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... free nationwide confidential legal consultations for users of Paxil who ... Defects, Attempted Suicide, Suicide and Addiction Issues. Individuals suffering from ... go to the firm’s website at http://www.ennislaw.com and ... ... (PRWEB) December 16, 2009 -- Bloomberg news ...
(Date:12/16/2009)... Foods will be carrying Dr. Shapio,s Help Hair Shake in all of ... ... (PRWEB) December 16, 2009 -- Dr. Larry Shapiro, hair transplant ... Foods stores will be carrying the Help Hair Whey Protein Shake. ... suitable as an adjunct for weight loss programs, working out and muscle ...
(Date:12/15/2009)... successfully developed a new electrophoretic method for detecting ... The technique, using SARCOSYL-PAGE, has specifically enhanced ... performance characteristics of SDS-PAGE for detecting other EPOs. ... grant from the World Anti-Doping Agency (WADA), appear ... and Analysis published by Wiley-Blackwell. , MIRCERA ...
(Date:12/15/2009)... SUMMARY: The U.S. Senate today rejected an ... Act that would have helped make prescription drugs ... legal importation of lower priced drugs from abroad. ... by Senators Dorgan, Snowe, McCain, Grassley and Stabenow, ... down the skyrocketing costs of prescription drugs. ,, ...
(Date:12/15/2009)... Bulletin Board: SNKTY), a Life Sciences company engaged in the research, development and commercialization of ... three resolutions that the Company had proposed at the Annual General Meeting of Shareholders held ... of Votes ... Non-, Matter ... For Against ...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake 2Health News:Researchers discover novel method for detecting MIRCERA 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3
... the human growth hormone (HGH) industry approaches $2 ... athletic performance, anti-aging and stimulating growth. Unfortunately, many ... of independent review organizations (IROs) whose members see ... medical necessity of growth hormone therapies ( www.nairo.org ...
... Network,s CIO on Helping Organizations Protect Medical Records and Comply ... ... Scottsdale, Ariz. (PRWEB) April 14, 2009 -- With an increasing ... of new challenges to implement administrative, technical and physical security ...
... flow measurement and control provider, announced that it has acquired ... Key Instruments is a flow meter manufacturer based in Trevose, ... flow meters, glass tube flow meters, electronic flow meters, and ... applications. , ...
... 14 Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: ... of a New Drug Application (NDA) to the U.S. ... relapsed or refractory aggressive non-Hodgkin,s lymphoma (NHL). CTI expects ... priority review which if granted could lead to an ...
... allow BlackBerry® devices to securely connect to ActiveSync supported email ... or businesses that require ActiveSync for their mobility solution such ... Suite or the CommuniGate Pro Server. , ... ...
... and PLANO, Texas, April 13 Botox,s arch-nemesis, ... the U.S. cosmetics ring at any moment; whether ... slightly unfamiliar European cousin remains to be seen, ... a significant potential cost savings, is certainly provocative. ...
Other Medicine News:Health News:IROs Help Determine Medical Necessity of Growth Hormone Therapy 2Health News:Lumension Webinar Focuses on How to Protect Medical Records, Ensure HIPAA Compliance and Improve Productivity 2Health News:Lumension Webinar Focuses on How to Protect Medical Records, Ensure HIPAA Compliance and Improve Productivity 3Health News:Brooks Instrument Acquires Flow Products Supplier Key Instruments 2Health News:Cell Therapeutics Initiating Rolling NDA Submission for Pixantrone 2Health News:Cell Therapeutics Initiating Rolling NDA Submission for Pixantrone 3Health News:Cell Therapeutics Initiating Rolling NDA Submission for Pixantrone 4Health News:NotifySync™ Provides BlackBerry a Direct Connection to Any Email Platform Supporting Microsoft ActiveSync 2Health News:Botox(R) vs. Reloxin(R) -- the Wrinkle Titans Poised for Battle 2Health News:Botox(R) vs. Reloxin(R) -- the Wrinkle Titans Poised for Battle 3Health News:Botox(R) vs. Reloxin(R) -- the Wrinkle Titans Poised for Battle 4
(Date:12/15/2009)... 15 West Pharmaceutical Services, Inc. (NYSE: ... Directors has approved payment of the first-quarter 2010 cash ... paid on February 3, 2010 to shareholders of record ... ,, West is a global manufacturer of components ... seals for vials, and closures and disposable components used ...
(Date:12/15/2009)... 15 SRI International, an independent nonprofit ... of U.S. patent 7,592,021 for a new bioadhesive ... drugs through the human body,s mucous membranes. This ... allows for a much longer release time compared ... Transmucosal delivery is an effective means to introduce ...
(Date:12/15/2009)... SINGAPORE, Dec. 15 ... that it has completed the previously announced ... manufacturer of disposable medical devices ranging from ... surgery. Through its medical segment, Flextronics provides ... device, medical equipment, and pharmaceutical customers. Terms ...
Breaking Medicine Technology:SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Flextronics Completes SloMedical Acquisition 2Uni H A in France Signs Purchasing Agreement for Masimo SET 28R 29 Pulse Oximetry Products 14907 1Uni H A in France Signs Purchasing Agreement for Masimo SET 28R 29 Pulse Oximetry Products 14907 2Uni H A in France Signs Purchasing Agreement for Masimo SET 28R 29 Pulse Oximetry Products 14907 3Uni H A in France Signs Purchasing Agreement for Masimo SET 28R 29 Pulse Oximetry Products 14907 4Macomb County Health Department Schedules Communitywide H1N1 Flu Vaccine Clinic Nov 24 61652 1Macomb County Health Department Schedules Communitywide H1N1 Flu Vaccine Clinic Nov 24 61652 2National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 1National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 2National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 3
... is Designed to Differentiate Squamous From, Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Classifying ... of 90 ... Percent., Accurate Diagnosis is Important ... Potential Higher Rates of Severe or Fatal Hemorrhage in Patients With Squamous ...
... 2 DermaGen AB today announced a,cash injection from ... Development and Ostersjostiftelsen. The capital will be used for,the ... be used to initiate a clinical phase 2a study ... has already received approval, and,to further develop the company,s ...
Other Medicine Technology:Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 2Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 3Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 4Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 5Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 6Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 7DermaGen AB Receives Over 1 Million Euros From a New Share Issue 2DermaGen AB Receives Over 1 Million Euros From a New Share Issue 3
MP-250N and 300N is a new style power supply. It is a versatile microprocessor power supply for horizontal or vertical gel electrophoresis. The unit is programmable and offers constant voltage and co...
Handy 100V Power Supply is Low-cost, compact and lightweight. Easy to operate - either 50 or 100 VDC is selectable as the output voltage. These voltages are sufficient for ordinary electrophoresis....
... ZOOM® Dual Power is a microprocessor-controlled ... both high voltage/low current and high ... voltage/low current section is ideal for ... DNA sequencing applications. The low voltage/high ...
... Power Supply is designed specifically ... extensive programming capabilities, including eight ... for you to set to ... intuitive PowerEase® interface is faster ...
Medicine Products: